Iliadin

Iliadin Dosage/Direction for Use

oxymetazoline

Manufacturer:

P&G Health

Distributor:

Zuellig Pharma
Full Prescribing Info
Dosage/Direction for Use
Adult nasal drops: Iliadin 0.05% Decongestant Nasal Drops is intended for intranasal application. Unless otherwise prescribed, instill 1-2 drops of Iliadin 0.05% Decongestant Nasal Drops into each nostril 2-3 times daily.
Iliadin 0.05% Decongestant Nasal Drops may only be administered to adults and children of 6 years and older and should not be used in small children and infants.
Children nasal drops: Iliadin 0.025 % Decongestant Nasal Drops may only be administered to children aged between one and six years and should not be used in infants under 1 year of age.
Iliadin 0.025% Decongestant Nasal Drops is intended for intranasal application. Unless otherwise prescribed, instill 1-2 drops of Iliadin 0.025% Decongestant Nasal Drops into each nostril 2-3 times daily.
Infant nasal drops: Iliadin 0.01% Decongestant Nasal Drops is intended for infants and small children. Up to the age of 4 weeks instill 1 drop of the 0.01% solution into each nostril 2-3 times daily.
From the 5th week of life until the age of 1 year, instill 1-2 drops into each nostril 2-3 times daily.
Instill the solution into each nostril. As the metered dropper bottle must be held in an upside-down position for application, Iliadin metered drops for infants can only be applied with the baby's head bent backwards.
Especially in the case of the 0.01% solution for infants 20 minutes may elapse before the onset of action.
0.01% decongestant nasal drops are intended for application in the nose only.
The single doses given for 0.01% decongestant nasal drops must not be administered more than 3 times daily.
Application for more than 10 consecutive days has to be prescribed by a physician.
A treatment-free period of several days should precede any repeated use.
Duration of treatment: Adult and children nasal drops: Unless specifically prescribed by the doctor, Iliadin 0.05% and 0.025% Decongestant Nasal Drops should only be used for short periods of time (up to 10 days). A treatment-free period of several days should precede any repeated use.
Permanent use of decongestant rhinological agents may attenuate their effect. The abuse of local rhinological agents may cause mucosal atrophy and reactive hyperaemia with rhinitis medicamentosa.
Longer use of oxymetazoline may cause damage to the mucosal epithelium with inhibition of ciliary activity. This may possibly result in irreversible damage to the mucosa with rhinitis sicca.
Long term use and overdosage must be avoided, especially in children. Medical supervision is indicated in patients with chronic rhinitis. Dosage higher than recommended may only be used under supervision.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in